ELEVEN BIOTHERAPEUTICS INC - COM (EBIO)

CUSIP: 286221106

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class
Equity / COM
Total 13F shares
14,190,910
Share change
+840,090
Total reported value
$40,017,705
Price per share
$2.82
Number of holders
39
Value change
-$16,862,515
Number of buys
27
Number of sells
30

Quarterly Holders Quick Answers

What is CUSIP 286221106?
CUSIP 286221106 identifies EBIO - ELEVEN BIOTHERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ELEVEN BIOTHERAPEUTICS INC - COM (EBIO) as of Q2 2015

As of 30 Jun 2015, ELEVEN BIOTHERAPEUTICS INC - COM (EBIO) was held by 39 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 14,190,910 shares. The largest 10 holders included Third Rock Ventures, LLC, FMR LLC, Flagship Ventures 2007 General Partner LLC, FRANKLIN RESOURCES INC, Redmile Group, LLC, ORBIMED ADVISORS LLC, VANGUARD GROUP INC, BlackRock Advisors LLC, State of New Jersey Common Pension Fund D, and BRIDGEWAY CAPITAL MANAGEMENT INC. This page lists 39 institutional shareholders reporting positions in this security for the Q2 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.